The US government maintained a network of more than 120 biological laboratories across more than 30 countries — facilities storing Ebola, Anthrax, SARS, Marburg, Plague, and at least seven other high-consequence pathogens.
Officials at the highest levels denied their existence. Those who said otherwise were labeled foreign agents and traitors to America.
That denial ended June 12, 2026, when outgoing Director of National Intelligence Tulsi Gabbard published declassified evidence confirming the network’s existence, its scope, and decades of deliberate concealment from the public.
What the ODNI press release describes is not a bureaucratic correction. It is an official acknowledgment that a global biological research network — one handling some of the most dangerous pathogens known to science — was knowingly withheld. The withholding was systematic. It was enforced.
What the Declassified Documents Show
The ODNI statement and its accompanying declassified slides confirm over 120 US-funded biolabs operating in more than 30 countries. Ukraine alone accounts for more than 40 of those facilities.
The documents name the pathogens stored there: Anthrax, tularemia, tuberculosis, MERS, SARS, Marburg, Ebola, Lassa, Plague, and Rickettsia. This is not a list of abstract biological risks. It is a catalogue of humanity’s most lethal infectious agents.
The primary US contractor was Black & Veatch. Cost documentation for four Ukrainian facilities named in the declassified slides totals more than $9.25 million in US government spending — covering labs in Kherson, Zakarpattia, Odessa, and Kyiv.
These were not improvised arrangements. Ukrainian subcontractors, Ministry of Health permits, and formal “Especially Dangerous Pathogen” certification protocols governed the work. US funding also covered genomic studies of highly pathogenic avian flu inside those same biocontainment facilities.
The Intelligence Community had separately warned, in internal assessments, that at least one US-funded Ukrainian biolab “likely housed dangerous pathogens” and remained vulnerable to Russian attack or seizure. That warning existed before the Russian invasion of 2022. It was not made public. The labs were a known security liability. The public bore the risk without knowing it.
Gain-of-Function Research and the COVID Ledger
Gabbard’s ODNI confirmed that many of these labs “are currently or have previously engaged in research using hazardous and highly contagious pathogens, in some cases including dangerous gain-of-function research, with very little visibility or oversight.”
Gain-of-function research modifies existing organisms to enhance their transmissibility, lethality, or host range — capabilities that, by definition, increase pandemic potential.
More than $1.4 billion in US government funds went toward overseas gain-of-function experiments between 2014 and 2023, according to Newsweek’s May 2026 reporting. The Office of the Inspector General previously acknowledged it could not determine how many potentially pandemic-capable pathogens were under active research in China or other nations.
Among the documented experiments: US-funded bat coronavirus research at the Wuhan Institute of Virology produced strains 10,000 times more infectious than baseline — a finding the National Institutes of Health later confirmed violated grant terms.
The COVID-19 pandemic killed nearly 14.9 million people in excess of normal mortality in 2020 and 2021 alone, according to World Health Organization estimates. Whether its origins connect to this system of unaccountable overseas research has not been officially answered. That question has only been managed — and the management of it is now part of the record Gabbard has declassified.
Ukraine as a Biological Frontier
Ukraine’s position in this network carries a specific history. Since 2005, the US invested approximately $200 million in 46 Ukrainian laboratories and health facilities through the Pentagon’s Biological Threat Reduction Program, a component of the post-Cold War Cooperative Threat Reduction program.
The original stated rationale was securing Soviet-era pathogen stockpiles and redirecting former bioweapons scientists toward civilian science. That rationale is not entirely fabricated — it documents real concerns about post-Soviet biological materials.
What the public understood as a biosecurity stabilization effort was far more extensive than advertised. The declassified slides show that the same facilities hosting disease-monitoring labs also trained Ukrainian scientists in “Especially Dangerous Pathogen” certification protocols and stored pathogen repositories from the Soviet anti-plague network.
The contractor network extended beyond Ukraine. Black & Veatch and the Defense Threat Reduction Agency signed contracts estimated at $215 million between 2008 and 2017 for lab construction in Azerbaijan, Cameroon, Thailand, Ethiopia, Vietnam, and Armenia, among others.
When the Russian invasion began in February 2022, the IC identified those Ukrainian labs as a live vulnerability. DTRA paused its Ukraine biological program that year. Per the declassified slides, it quietly resumed operations in 2023 under a rebranded program name, with no public announcement.
Official Denial and Its Enforcement
Gabbard’s statement names the suppression directly: the information was “intentionally covered up by powerful people,” who asserted the labs did not exist and accused those who said otherwise of being “foreign assets and traitors to America.”
This is not a characterization of a rogue actor. It describes a sustained institutional posture maintained across multiple administrations.
When the Russian invasion of Ukraine brought these labs into public discussion in 2022, Western media classified the story as disinformation. Fact-checkers dismissed it. Under bilateral agreements, Ukraine was contractually prohibited from making public disclosures about the program.
The private companies that built and managed these facilities operated under military agency channels with no mechanism for public account to be rendered. Those who raised the issue were not answered. They were discredited.
The populations living nearest to these facilities bore the containment risk without access to the information necessary to assess it. The new ODNI guidance Gabbard issued directs increased intelligence collection on these labs and has already produced new details on active clinical trials — details the ODNI describes as raising “significant ethical, financial, and security concerns” about what have been publicly framed as routine public health initiatives.
Trump’s executive order EO 14292, signed May 25, 2025, banned federal funding of gain-of-function research worldwide. The order closes the mechanism for future programs of this kind. It does not address who directed two decades of operations, or to whom account for those operations will be rendered.
